Full Press Release Details
ALX Oncology to Host Virtual Company Event Highlighting New Clinical Data Presented at SABCS 2024.
ALXO
ALX Oncology to Host Virtual Company Event Highlighting New Clinical Data Presented at SABCS 2024
Key Takeaway: ALX Oncology to Host Virtual Company Event Highlighting New Clinical Data Presented at SABCS 2024
Price reaction · baseline $1.51 (2024-12-11 close) · hit after-hours · clean, no other ALXO news in the window
day 0 close
-6%
day 1
-4%
day 3 · peak
+18.5%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+102%
120-day peak, hindsight
Typical move
7.9%
average across 6 past catalysts
Cash runway
~25 mo
Minimal dilution risk
Lead asset
ALX2004
Phase 1 · NSCLC (Advanced Non-small Cell Lung Cancer)